Gts Securities LLC Edwards Lifesciences Corp Call Options Transaction History

Gts Securities LLC

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	SELL	$72.54 - $95.56 $1.49 Million - $1.97 Million	-20,600 Reduced 40.63%	30,100 $2.88 Million
Q4 2023 Feb 14, 2024	SELL	$61.71 - $77.76 $487,509 - $614,304	-7,900 Reduced 13.48%	50,700 $3.87 Million
Q3 2023 Nov 15, 2023	BUY	$69.28 - $93.38 $4.06 Million - $5.47 Million	58,600 New	58,600 $4.06 Million

1,376

454M

3.86M

3.32M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $56.4B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Gts Securities LLC with notifications on news.